{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-21-009802","form_type":"8-K","ticker":"TCMD","cik":"0001027838","company_name":"TACTILE SYSTEMS TECHNOLOGY INC","filed_at":"2021-08-02T23:59:59+00:00","discovered_at":"2026-05-14T18:04:16.899769+00:00","generated_at":"2026-06-29T23:43:50.889629+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Tactile Medical Q2 revenue up 45% to $51.1M, net income $1.3M; raises FY guidance low end","bullets":["Q2 revenue $51.1M (+45% YoY); net income $1.3M vs loss of $13.9M; diluted EPS $0.07 vs loss of $0.72.","Adjusted EBITDA $4.1M vs loss of $0.7M; operating loss narrowed to $0.1M from $8.0M.","Updated FY2021 revenue guidance: $216.3M–$224.5M (growth 16%–20%), low end raised from prior $215.3M.","Appointed Eric Pauls as SVP of Sales effective May 1, succeeding Bryan Rishe.","Restated credit facility with Wells Fargo: $25M revolving with $30M accordion (up to $55M), replacing $10M facility."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-21-009802","json":"https://secwatch.observer/filing/0001558370-21-009802.json","markdown":"https://secwatch.observer/filing/0001558370-21-009802.md","text":"https://secwatch.observer/filing/0001558370-21-009802.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1027838/000155837021009802/0001558370-21-009802-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1027838/000155837021009802/tcmd-20210802x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T23:43:50.889629+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}